ArticleCancer biology & therapy2012

Oridonin in combination with imatinib exerts synergetic anti-leukemia effect in Ph+ acute lymphoblastic leukemia cells in vitro by inhibiting activation of LYN/mTOR signaling pathway.

Yong Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.